128 related articles for article (PubMed ID: 8837383)
21. Study of chronic hemolytic anaemia patients in Rio de Janeiro: prevalence of anti-human parvovirus B19 IgG antibodies and the development aplastic crises.
Sant'Anna AL; Garcia Rde C; Marzoche M; da Rocha HH; Paula MT; Lobo CC; Nascimento JP
Rev Inst Med Trop Sao Paulo; 2002; 44(4):187-90. PubMed ID: 12219109
[TBL] [Abstract][Full Text] [Related]
22. The prevalence and persistence of human parvovirus B19 infection in thalassemic patients.
Siritantikorn S; Kaewrawang S; Siritanaratkul N; Theamboonlers A; Poovorawan Y; Kantakamalakul W; Wasi C
Asian Pac J Allergy Immunol; 2007; 25(2-3):169-74. PubMed ID: 18035805
[TBL] [Abstract][Full Text] [Related]
23. Low seroprevalence of parvovirus B19 in Taiwanese children and young adults.
Su WJ; Ni YH; Liu DP; Chiou LS; Cheng WY; Wu JS; Lu CY
Pediatr Neonatol; 2010 Oct; 51(5):265-8. PubMed ID: 20951355
[TBL] [Abstract][Full Text] [Related]
24. Seroprevalence of parvovirus B19 IgG in children affected by juvenile idiopathic arthritis.
Weissbrich B; Süss-Fröhlich Y; Girschick HJ
Arthritis Res Ther; 2007; 9(4):R82. PubMed ID: 17760961
[TBL] [Abstract][Full Text] [Related]
25. Age-related immunoglobulin G seroprevalence of human parvovirus B-19 in Israeli children.
Miron D; Horovitz Y; Luder A; Ohnona FS; Schlesinger Y
Isr Med Assoc J; 2010 May; 12(5):277-9. PubMed ID: 20929079
[TBL] [Abstract][Full Text] [Related]
26. The prevalence of antibody to human parvovirus B19 in pregnant women in Kuwait.
Maksheed M; Pacsa AS; Essa SS; Ahmed MA; Monem RA; Surkouh M
Acta Trop; 1999 Oct; 73(3):225-9. PubMed ID: 10546839
[TBL] [Abstract][Full Text] [Related]
27. Persistent parvovirus B19 infections in immunocompromised children.
Flunker G; Peters A; Wiersbitzky S; Modrow S; Seidel W
Med Microbiol Immunol; 1998 Mar; 186(4):189-94. PubMed ID: 9574901
[TBL] [Abstract][Full Text] [Related]
28. [Seroprevalence of human parvovirus B 19 antibodies (Sticker's disease/erythema infectiosum) in the DRG population].
Wiersbitzky S; Schwarz TF; Bruns R; Jäger G; Bittner S; Weidemann H; Deinhardt F; Hottenträger B; Abel E; Ladstätter L
Kinderarztl Prax; 1990 Apr; 58(4):185-9. PubMed ID: 2164118
[TBL] [Abstract][Full Text] [Related]
29. [Comparative study of indirect immunofluorescence (IIF) and ELISA techniques in the detection of parvovirus B19].
González M; Hassanhi M; Rivera S; Bracho MP
Invest Clin; 2000 Mar; 41(1):19-27. PubMed ID: 10758696
[TBL] [Abstract][Full Text] [Related]
30. Prevalence and genotypic characterization of Human Parvovirus B19 in children with measles- and rubella-like illness in Iran.
Rezaei F; Sarshari B; Ghavami N; Meysami P; Shadab A; Salimi H; Mokhtari-Azad T
J Med Virol; 2016 Jun; 88(6):947-53. PubMed ID: 26538067
[TBL] [Abstract][Full Text] [Related]
31. Serologic study on parvovirus b19 infection in childhood acute lymphoblastic leukemia during chemotherapy: clinical and hematologic implications.
Heegaard ED; Schmiegelow K
J Pediatr Hematol Oncol; 2002; 24(5):368-73. PubMed ID: 12142785
[TBL] [Abstract][Full Text] [Related]
32. Antibody-mediated opsonization of red blood cells in parvovirus B19 infection.
Chehadeh W; Halim MA; Al-Nakib W
Virology; 2009 Jul; 390(1):56-63. PubMed ID: 19450862
[TBL] [Abstract][Full Text] [Related]
33. Low prevalence of active parvovirus B19 infection in HIV-infected patients.
Raguin G; Leruez-Ville M; Gregoire V; Deplanche M; Leport C; Morinet F; Vilde JL
Eur J Clin Microbiol Infect Dis; 1997 Oct; 16(10):760-2. PubMed ID: 9405950
[TBL] [Abstract][Full Text] [Related]
34. High frequencies of exposure to the novel human parvovirus PARV4 in hemophiliacs and injection drug users, as detected by a serological assay for PARV4 antibodies.
Sharp CP; Lail A; Donfield S; Simmons R; Leen C; Klenerman P; Delwart E; Gomperts ED; Simmonds P
J Infect Dis; 2009 Oct; 200(7):1119-25. PubMed ID: 19691429
[TBL] [Abstract][Full Text] [Related]
35. Seroprevalence of parvovirus B19 IgG and IgM antibodies among pregnant women in Oyo State, Nigeria.
Abiodun I; Opaleye OO; Ojurongbe O; Fagbami AH
J Infect Dev Ctries; 2013 Dec; 7(12):946-50. PubMed ID: 24334941
[TBL] [Abstract][Full Text] [Related]
36. A population-based epidemiological survey of human parvovirus B19 infection: a project of the Kyushu and Okinawa Population Study (KOPS).
Ihara T; Furusyo N; Hayashi T; Toyoda K; Murata M; Hayashi J
Arch Virol; 2013 Dec; 158(12):2465-72. PubMed ID: 23775357
[TBL] [Abstract][Full Text] [Related]
37. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection.
Von Landenberg P; Lehmann HW; Knöll A; Dorsch S; Modrow S
Arthritis Rheum; 2003 Jul; 48(7):1939-47. PubMed ID: 12847688
[TBL] [Abstract][Full Text] [Related]
38. Gender differences in the relationship of anti-parvovirus B19 IgG with antinuclear antibody and C-reactive protein in clinical adult serum samples.
O'Bryan TA; Naides SJ
Rheumatol Int; 2010 Feb; 30(4):551-4. PubMed ID: 20012869
[TBL] [Abstract][Full Text] [Related]
39. Influenza A and Parvovirus B19 Seropositivity Rates in Gabonese Infants.
Gabor JJ; Schwarz NG; Esen M; Kremsner PG; Grobusch MP
Am J Trop Med Hyg; 2015 Aug; 93(2):407-9. PubMed ID: 26055747
[TBL] [Abstract][Full Text] [Related]
40. Seroprevalence of parvovirus B19 NS1-specific IgG in B19-infected and uninfected individuals and in infected pregnant women.
Hemauer A; Gigler A; Searle K; Beckenlehner K; Raab U; Broliden K; Wolf H; Enders G; Modrow S
J Med Virol; 2000 Jan; 60(1):48-55. PubMed ID: 10568763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
